Research and development and prototype validation aimed at creating synergies with the DX promotion business
First written in FY2023-Q2. 3 of 7 entries say "Restated". Latest entry: 2026-05-22.
No other company in this theme has enough history to compare yet.
- 2026-05-22AdvancedResults presentation
「This product is an AI-agent platform provided by FCE Inc. and created through joint development with PKSHA Technology Inc.」
The company’s efforts involving joint development and verification with an external company have progressed to the commercialization of a specific AI-agent platform. - FY2026-H1Resumption of research and development activitiesAnnual report
「During the current interim consolidated accounting period, research and development activities focused on exploring areas capable of creating synergies with the existing DX Promotion Business. We selected fields closely related to the DX Promotion Business and continued our daily research to overcome the challenges of linking potential businesses in those fields with our existing products and improving cost performance, as prerequisites for commercialization. Our research and development structure involved joint development with an external group company that is our research and development partner. We completed a prototype product and conducted experiments and validation to confirm and assess whether it could be implemented by client companies. We will continue to advance these activities effectively and promptly. No research and development expenses were recorded for the current interim consolidated accounting period.」
Research and development activities, which were described as “not applicable” in the previous fiscal year, have been described again. The Group is conducting joint development with external companies, completing prototypes, and carrying out experiments and validation at client companies, but has not recorded any research and development expenses. - FY2025DroppedAnnual report
「6. Research and Development Activities: Not applicable.」
The current period contains no description of research and development activities, whereas joint development with external companies, prototype validation, and research and development expenses had been described previously. - FY2024-Q2RestatedAnnual report
「Our research and development structure involved joint development with an external group company that is our research and development partner. We completed a prototype product and conducted experiments and validation to confirm and assess whether it could be implemented by client companies. We will continue to advance these activities effectively and promptly. The total research and development expenses incurred by the Group during the cumulative six-month period of the current fiscal year were ¥1 million.」
The Group continues joint development with external companies, completion of prototype products, and experiments and validation at client companies. Research and development expenses were ¥1 million, with no new stage of progress noted. - FY2024-Q1RestatedAnnual report
「Our research and development structure involved joint development with an external group company that is our research and development partner. We completed a prototype product and conducted experiments and validation to confirm and assess whether it could be implemented by client companies. We will continue to advance these activities efficiently and promptly. The total research and development expenses incurred by the Group during the cumulative three-month period of the current fiscal year were ¥1 million.」
The Group continues joint development with external companies, completion of prototype products, and experiments and validation at client companies. Research and development expenses were ¥1 million, and no new stage of progress was noted since the previous quarter. - FY2023-Q3RestatedAnnual report
「Our research and development structure involved joint development with an external group company that is our research and development partner. We completed a prototype product and conducted experiments and validation to confirm and assess whether it could be implemented by client companies. We will continue to advance these activities effectively and promptly. The total research and development expenses incurred by the Group during the cumulative nine-month period of the current fiscal year were ¥1 million.」
The Group continues joint development with external companies aimed at creating synergies with its existing DX Promotion Business, as well as prototype completion and experiments and validation at client companies. Research and development expenses were ¥1 million, with no new stage of progress noted since the previous quarter. - FY2023-Q2First statedAnnual report
「During the cumulative six-month period of the current fiscal year, research and development activities focused on exploring areas capable of creating synergies with the existing DX Promotion Business. We selected fields closely related to the DX Promotion Business and continued our daily research to overcome the challenges of linking potential businesses in those fields with our existing products and improving cost performance, as prerequisites for commercialization. Our research and development structure involved joint development with an external group company that is our research and development partner. We completed a prototype product and conducted experiments and validation to confirm and assess whether it could be implemented by client companies. We will continue to advance these activities effectively and promptly. The total research and development expenses incurred by the Group during the cumulative six-month period of the current fiscal year were ¥1 million.」
The Group selected related fields to create synergies with its existing DX Promotion Business and is conducting joint development with external companies, completing prototype products, and carrying out experiments and validation at client companies. Research and development expenses for the cumulative second quarter were ¥1 million.